Page 9 - Pascal Prigent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pascal prigent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pascal Prigent Today - Breaking & Trending Today

GENFIT (GNFT) to Acquire Versantis

GENFIT (GNFT) to Acquire Versantis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , France General , United Kingdom , Pascal Prigent , Officerand Meriam Kabbaj , Vincent Forster , European Medicines Agency , Drug Administration , Orphan Drug Designation , Rare Pediatric Diseases Designation , Chief Executive Officer , Chief Scientific Officerand Meriam Kabbaj , Chief Operations Officer , Board Members , Pediatric Review Voucher ,

GENFIT to acquire Versantis to expand liver disease portfolio

GENFIT is set to acquire Versantis, a Swiss biotechnology company focused on addressing the growing unmet medical needs in liver diseases. ....

Pascal Prigent , European Medicines Agency , Drug Administration , Rare Pediatric Diseases Designation , Pediatric Review Voucher ,

Genfit to Acquire Versantis, Expanding its Portfolio in Liver Diseases

Genfit to Acquire Versantis, Expanding its Portfolio in Liver Diseases
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United States , Pascal Prigent , European Medicines Agency , Drug Administration , Priority Review Voucher , Orphan Drug , Rare Pediatric Diseases ,

Genfit spreads its bets in a rare liver disease with buyout of Phase 2-ready biotech

Liver disease remains the focus of Genfit, despite a high-profile clinical trial failure in the fatty liver disease NASH. The company is building out its pipeline by acquiring Versantis, a clinical-stage biotech whose most advanced drug candidate brings a novel approach to treating a deadly chronic liver disease complication that has no FDA-approved therapies. ....

Pascal Prigent , France Based Genfit , Switzerland Based Versantis , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens , Iagnostics Company , Iagnostic Platforms , Minimally Invasive Surgery , Aser Surgery , Ealth And Wellness , Mployee Wellness Programs , Hanghai Innovation Center , R D , Twin Cities ,